QVF — Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings Class II

FDA Device Classification

Classification Details

Product Code
QVF
Device Class
Class II
Regulation Number
866.3982
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an aid in the diagnosis of SARS-CoV-2 infections COVID-19). The device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The design and procedures of the device are appropriate for use by healthcare professionals in near-patient settings outside a centralized laboratory

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K251289guangzhou wondfo biotech coWELLlife COVID-19 Antigen Test RxOctober 22, 2025
K243872becton, dickinson andBD Veritor System for SARS-CoV-2June 16, 2025
K250273abbott diagnostics scarboroughBinaxNOW COVID-19 Ag CardJune 13, 2025
K233358inbios internationalSCoV-2 Ag Detect Rapid TestAugust 23, 2024
K232377healgen scientificHealgen Rapid COVID-19 Antigen TestApril 19, 2024
K231187nano-ditech corporationNano-Check™ COVID-19 Antigen TestJanuary 23, 2024
K233688quidel corporationSofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetDecember 13, 2023
DEN220039quidel corporationSofia 2 SARS Antigen+ FIA, Sofia 2 SARS Antigen+ FIA Control Swab SetMarch 8, 2023